DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog

Update: AstraZeneca Wins EU Approval For Lynparza

Tax Inversions Wrap Up

AstraZeneca, oil shares contribute to FTSE 100’s advance

Is A Dividend Cut The End Of The World? Analysis Of Dividend-Cutting Companies, Part I

Vanguard FTSE Europe ETF Experiences Big Outflow

3 Reasons GlaxoSmithKline PLC Could Soar in 2015

GlaxoSmithKline shareholders have suffered through a rough year, but these three catalysts could send its stock soaring in 2015.

Theravance Biopharma Pipeline Valuation

Health Care Sector Update for 12/15/2014: ADXS, AZN, OPK, SHS, PFE

3 Stocks That Might Slash Their Dividends in 2015

These three companies all offer sector-beating dividend yields. But with each facing serious headwinds, can they maintain these huge yields next year?
See More Articles...